Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 4, 2020
- Accepted July 11, 2020
- Published online July 30, 2020.
Copyright & Usage
Copyright ©ERS 2020 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- Theodoros V. Giannouchos1,
- Roberto A Sussman2,
- José M Mier3,4,
- Konstantinos Poulas5 and
- Konstantinos Farsalinos5,6
- 1Pharmacotherapy Outcomes Research Center, University of Utah, College of Pharmacy, Salt Lake City, USA
- 2Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Ciudad de México, México
- 3Clinica de Cáncer de Pulmón y Tumores del Tórax, Hospital Angeles Lomas, Hacienda de las Palmas, Huixquilucan, México
- 4Instituto de Cirugía Torácica Mínimamente Invasiva, Hospital Angeles Lomas, Hacienda de las Palmas, Huixquilucan, México
- 5Laboratory of Molecular Biology and Immunology, Department of Pharmacy, University of Patras, Rio – Patras, Greece
- 6Department of Public and Community Health, University of West Attica, Egaleo, Greece
- Konstantinos Farsalinos, MD, MPH. E-mail: kfarsalinos{at}gmail.com
Article usage
Altmetrics
Vol 57 Issue 2
Table of Contents
Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory–confirmed COVID-19 cases
